At B2Gold Corp's 2026 Annual General and Special Meeting, shareholders voted on key company matters with 63.06% turnout. All ten nominated directors were re-elected with strong support, and resolutions to appoint PricewaterhouseCoopers LLP as auditor and approve the Restricted Share Unit Plan passed with over 95% approval. The advisory vote on executive compensation received 70.46% support. These results affirm shareholder confidence and set the stage for B2Gold's continued governance and operational plans.
Jim Rickards highlights a tiny $2 stock holding exclusive rights to a massive $2.7 trillion mineral deposit in the US, containing gold, copper, silver, and critical metals vital for technology and defense. The project has been stalled by environmenta...
Aurion Resources Ltd. shareholders overwhelmingly approved a plan for Agnico Eagle Mines Limited to acquire all outstanding Aurion shares at C$2.60 each. The approval was secured at a special meeting, with over 99% voting in favor. The transaction no...
Anika Therapeutics granted 3,360 restricted stock units (RSUs) to a newly hired non-executive employee on June 1, 2026. This grant was made under the company's 2021 Inducement Plan as a material inducement for accepting employment, in compliance with...
Boralex Inc. has received final approval from the Superior Court of Québec for its arrangement with BIF Thunder Holdings Inc., jointly owned by Brookfield Infrastructure Fund V and Caisse de dépôt et placement du Québec. This approval follows shareho...
Arcutis Biotherapeutics awarded 44,000 restricted stock units to six newly hired employees as part of its 2022 Inducement Plan, approved by its board's Compensation Committee. These stock units vest over four years, with 25% vesting annually, conting...
